Page last updated: 2024-08-25

triheptanoin and Fasting Hypoglycemia

triheptanoin has been researched along with Fasting Hypoglycemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Berry, G; Burton, B; Cataldo, J; Chapman, K; Grunewald, S; Longo, N; Lu, X; Murphy, E; Phillips, J; Sanchez-Valle, A; Tanpaiboon, P; Vockley, J	1

Trials

1 trial(s) available for triheptanoin and Fasting Hypoglycemia

Article	Year
Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study. Journal of inherited metabolic disease, 2021, Volume: 44, Issue:1 Topics: Adolescent; Adult; Cardiomyopathies; Child; Child, Preschool; Fatty Acids; Female; Humans; Hypoglycemia; Infant; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Oxidation-Reduction; Rhabdomyolysis; Triglycerides; United Kingdom; United States; Young Adult	2021

Article

Year

Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study.

Journal of inherited metabolic disease, 2021, Volume: 44, Issue:1

Topics: Adolescent; Adult; Cardiomyopathies; Child; Child, Preschool; Fatty Acids; Female; Humans; Hypoglycemia; Infant; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Oxidation-Reduction; Rhabdomyolysis; Triglycerides; United Kingdom; United States; Young Adult

2021